Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia

NCT04750317 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.

NCT NCT04750317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia
Lead sponsor
I.M. Sechenov First Moscow State Medical University
Phase
Phase 2
Overall status
Completed
Start date
May 11, 2020
Completion date
September 1, 2020
Enrollment
414 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19